Published guidance, NICE advice and quality standards | Guidance

Showing 251 to 260 of 330

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer	TA389	27 April 2016	27 April 2016
Guidance on the use of temozolomide for the treatment of recurrent malignant glioma (brain cancer)	TA23	26 April 2001	3 March 2016
Skin cancer prevention	PH32	26 January 2011	9 February 2016
Enzalutamide for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated	TA377	27 January 2016	27 January 2016
Ramucirumab for treating advanced gastric cancer or gastro–oesophageal junction adenocarcinoma previously treated with chemotherapy	TA378	27 January 2016	27 January 2016
Bladder cancer	QS106	17 December 2015	17 December 2015
Erlotinib and gefitinib for treating non-small-cell lung cancer that has progressed after prior chemotherapy	TA374	16 December 2015	16 December 2015
VivaScope 1500 and 3000 imaging systems for detecting skin cancer lesions	HTG388	11 November 2015	11 November 2015
Paclitaxel as albumin-bound nanoparticles with carboplatin for untreated non-small-cell lung cancer (terminated appraisal)	TA362	28 October 2015	28 October 2015
Bevacizumab for treating relapsed, platinum‑resistant epithelial ovarian, fallopian tube or primary peritoneal cancer (terminated appraisal)	TA353	26 August 2015	26 August 2015